Main Business：主要产品包括4K荧光内窥镜摄像系统、医用冷光源、医用气腹机、4K医用监视器等，覆盖泌尿、肝胆、心胸、普外、妇科等科室Company Type：Medical Device Supplier
Size：1-49人
Capital：1万RMB
Establishment：2022
Sell：主要产品包括4K荧光内窥镜摄像系统、医用冷光源、医用气腹机、4K医用监视器等，覆盖泌尿、肝胆、心胸、普外、妇科等科室
Chenxin Medical was founded in October 2022. It is an innovation‑driven national‑level high‑tech enterprise devoted to the R&D, production and commercialization of 4K, 3D and ICG endoscopic imaging devices.
Backed by robust research‑and‑development capabilities, the company stands at the forefront of domestic‑made medical‑device innovation and facilitates leap‑forward advancement of home‑grown equipment from clear visualization and precise identification to authentic real‑scene presentation. Over 70 percent members of its R&D team hold master’s or doctoral degrees, and the firm has been granted 10 authorized invention patents. Its products have demonstrated outstanding merits and earned rising recognition from medical specialists, market participants and investment institutions. The products are applied across seven clinical departments including urology, hepatobiliary surgery, cardiothoracic surgery, general surgery and gynecology, with installations completed in more than 100 Grade‑A tertiary hospitals nationwide. Committed to comprehensive deployment in precision‑medicine fields, Chenxin Medical strives to further popularize minimally‑invasive surgeries and improve relevant treatment outcomes.
Chenxin Medical focuses on independent R&D and industrialization of medical endoscopic camera systems. It ranks among China’s first‑batch enterprises to secure registration and manufacturing approvals for the 4K‑3D fluorescent endoscopic camera system. Its commercially‑available products cover 4K‑3D fluorescent endoscopic camera systems, 4K‑3D fluorescent video endoscopes, cold light sources for medical endoscopes, medical insufflators and 4K‑3D medical monitors.
Furthermore, its cutting‑edge products including Chenxin Computer‑Assisted Surgery (CAS) intraoperative navigation system and laparoscopic surgical robot incorporating multiple advanced technologies are pending market launch. CE and FDA certifications for multiple products will be approved shortly. All these products are independently developed by Chenxin Medical with proprietary intellectual‑property rights. The company maintains in‑depth cooperation with top‑tier clinicians so that its technologies originate from clinical requirements and serve clinical practice.